Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex
Phase 1
Completed
- Conditions
- Epidermolysis Bullosa Simplex
- Interventions
- Drug: Vehicle Topical Gel
- First Posted Date
- 2021-09-30
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- BioMendics, LLC
- Target Recruit Count
- 6
- Registration Number
- NCT05062070
- Locations
- 🇺🇸
Stanford University School of Medicine, Dermatology Department, Redwood City, California, United States
Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants
Phase 2
Completed
- Conditions
- Wound Healing
- Interventions
- Drug: Topical Vehicle Gel
- First Posted Date
- 2019-09-12
- Last Posted Date
- 2021-06-24
- Lead Sponsor
- BioMendics, LLC
- Target Recruit Count
- 72
- Registration Number
- NCT04088357
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸J&S Studies, College Station, Texas, United States
Safety and Efficacy of Topical TolaSure on Skin Punch Biopsies in Healthy Participants
- First Posted Date
- 2018-08-08
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- BioMendics, LLC
- Target Recruit Count
- 22
- Registration Number
- NCT03620175
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath